First human tests of ZE46-0134 drug completed safely
NCT ID NCT06399315
First seen Jan 04, 2026 · Last updated May 10, 2026 · Updated 20 times
Summary
This early-stage study tested a new drug called ZE46-0134 in 112 healthy volunteers to see if it is safe and how the body handles it. The drug is being developed for a type of blood cancer called AML. The study is now complete, and the results will help decide if further testing in patients is possible.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AML are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Linear Clinical Research Ltd
Perth, Nedlands, WA 6009, Australia
Conditions
Explore the condition pages connected to this study.